Gabapentin
Product Images NDC 53002-6423

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 53002-6423). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

This is a line graph depicting mean pain scores over 8 weeks comparing Placebo and Gabapentin 3600 mg/day. The X-axis shows weeks, including a 4-week dose titration period followed by a 4-week fixed dose period. The Y-axis represents mean pain scores from 0 to 10. Gabapentin shows a declining pain score trend, while placebo remains relatively stable.*

FDA Label Image

Figure 2 (Image 02)

Line graph depicting mean pain scores over 7 weeks for placebo and gabapentin at daily doses of 1800 mg and 2400 mg. The graph shows changes during a 3-week dose titration period followed by a 4-week fixed dose period, comparing pain score trends among the three groups.*

FDA Label Image

Figure 3 (Image 03)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies.' It compares placebo (PBO) and Gabapentin (GBP) at different dosages across two studies. The vertical axis shows percentages from 0% to 100%, indicating the proportion of responders. Study 1 compares placebo with GBP 3600 mg, and Study 2 compares placebo with GBP 1800 mg and GBP 2400 mg. Percentages for each group are labeled above the bars, showing higher responder rates for gabapentin doses compared to placebo.*

FDA Label Image

Cockcroft And Gault Equation (Image 04)

An illustration showing the formula for calculating creatinine clearance (CLCr). The formula is: [(140 - age in years) x weight in kg] divided by [72 x serum creatinine in mg/dL], multiplied by 0.85 for female patients.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure of gabapentin, showing the molecular arrangement with a cyclohexane ring, an amino group (CH2NH2), and a carboxyl group (CH2CO2H) attached to the ring.*

FDA Label Image

Image-09 (Image 09)

A scatter plot showing the percentage difference on the y-axis against daily dose in mg on the x-axis for Gabapentin in three studies labeled as Study a, Study b, and Study c. The graph uses different colored square markers to represent data points for each study across varying doses from 600 mg to 1800 mg.*

FDA Label Image

Label Image (Lbl530026423)

Gabapentin 300 mg capsules packaging label from RPK Pharmaceuticals, Inc. The label shows instructions to take 1 capsule 3 times a day or as directed. It also includes various lot, reference, and billing numbers, barcode, refill information, and placeholders for clinic name, prescriber name, patient name, and dates. The label states Rx only and shows a 100 capsule count.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.